FDA Grants Approval for Flecainide Acetate ANDA218093 by OMSAV PHARMA
The FDA has granted approval for the ANDA218093 application for Flecainide Acetate submitted by OMSAV PHARMA.
Company
Pharmaceutical intelligence for OMSAV PHARMA with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No signals indexed for this entity yet.
No signals indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.